3 ms·
That’s absurd and you just made it up. Easily verified through public info. Take Pfizer, R&D is $11B. You think executive comp is more than $11B? The CEO to
by refurb 3y ago
That’s absurd and you just made it up. Easily verified through public info.
Take Pfizer, R&D is $11B. You think executive comp is more than $11B?
The CEO total comp is $24M or 2%. The exec team is less than 10 people.
At least try to make believable claims.
- gruez 3y agoHe's probably referring to this article: https://news.ycombinator.com/item?id=39405547 https://news.ycombinator.com/item?id=39405547 that made the rounds a few weeks ago, and bungled the meaning ("executive compensation / stock" rather than "executives and stockholders than on R&D").
- oaiey 3y agoCorrect. I see this from the perspective of the society overall. I do not care whether the money goes to the CEO, a mid-level executive, a sales rep or the stock divident/buyback etc. What matters is how much money from the dollar I spend on a drug goes to research and how much into cost of production. Every other cent is something which has to be under scrutiny like is any tax dollar. Healthcare is like water, food, and shelter an elementary human need. Excessive profiteering or waste on it is just wrong.